Tobias Neher

University of Southern Denmark
Country flagDenmark

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (25)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Hearing aids provide nonlinear amplification to improve speech audibility and loudness perception. While more audibility typically increases speech intelligibility at low levels, the same is not true for above-conversational levels, where decreases in intelligibility (“rollover”) can occur. In a previous study, we found rollover in speech intelligibility measurements made in quiet for 35 out of 74 test ears with a hearing loss. Furthermore, we found rollover occurrence in quiet to be associated with poorer speech intelligibility in noise as measured with linear amplification. Here, we retested 16 participants with rollover with three amplitude-compression settings. Two were designed to prevent rollover by applying slow- or fast-acting compression with a 5:1 compression ratio around the “sweet spot,” that is, the area in an individual performance-intensity function with high intelligibility and listening comfort. The third, reference setting used gains and compression ratios prescribed by the “National Acoustic Laboratories Non-Linear 1” rule. Speech intelligibility was assessed in quiet and in noise. Pairwise preference judgments were also collected. For speech levels of 70 dB SPL and above, slow-acting sweet-spot compression gave better intelligibility in quiet and noise than the reference setting. Additionally, the participants clearly preferred slow-acting sweet-spot compression over the other settings. At lower levels, the three settings gave comparable speech intelligibility, and the participants preferred the reference setting over both sweet-spot settings. Overall, these results suggest that, for listeners with rollover, slow-acting sweet-spot compression is beneficial at 70 dB SPL and above, while at lower levels clinically established gain targets are more suited.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (9)

Jesper Hvass Schmidt

Odense University Hospital

DENMARK
View details

Tim Jürgens

Professor

University of Luebeck

GERMANY
View details

Harvey Dillon

Macquarie University

AUSTRALIA
View details

Raul Sanchez Lopez

Institute for Globally Distributed Open Research and Education

DENMARK
View details

Michael Gaihede

Professor, MD, PhD,

Aalborg Universitet Det Sundhedsvidenskabelige Fakultet

DENMARK
View details

Lindsey Van Yper

Macquarie University

AUSTRALIA
View details

Dorte Hammershøi

Aalborg University

DENMARK
View details

Dan Dupont Hougaard

Aalborg University

DENMARK
View details

Christian Godballe

University of Southern Denmark

DENMARK
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.